Skip to main content
. 2021 Dec 3;13(12):2067. doi: 10.3390/pharmaceutics13122067

Table 2.

Oligonucleotides used in this study.

Entry Oligonucleotide Sequence
1 Control 1 5′-ACGUGACACGTTCGGAGAAUU-3′
2 Control 2 5′-UGCGCTCCTGGACGTAGCCU-3′
3 Gapmer p53.1 5′-CAAAGCTGTTCCGTCCCAGU-3′
4 Gapmer p53.2 5′-GACUCCAGTGGTAATCTAC-3′
5 Gapmer p53.3 5′-GAAAUTTGCGTGTGGAGUA-3′
6 Gapmer p53.4 5′-GGACATACCAGCTTAGAUUUU-3′